ORIC Pharmaceuticals, Inc.
ORIC Pharmaceuticals, Inc. (ORIC) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ORIC · as of Jun 8, 2026
Activity summary
Buy transactions
2
P-Purchase only
Sell transactions
21
12 Months
Buy/Sell ratio
0.10
Buy/Sell (by trades)
Overall sentiment
ORIC Pharmaceuticals, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
ORIC insider buying and selling by quarter
ORIC insider selling · ORIC insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · ORIC ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
ORIC executive sell shares · ORIC board member insider trading · ORIC insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Feb 24, 2026 | Piscitelli Dominic CFO | Option | 52,000 | $227K | Form 4 |
| Feb 24, 2026 | Piscitelli Dominic CFO | Sale | 52,000 | $703K | Form 4 |
| Jan 16, 2026 | Heyman Richard A. Director | Sale | 3,200 | $38K | Form 4 |
| Jan 16, 2026 | Heyman Richard A. Director | Sale | 3,500 | $42K | Form 4 |
| Dec 15, 2025 | Multani Pratik S Chief Medical Officer | Option | 29,333 | — | Form 4 |
| Dec 16, 2025 | Multani Pratik S Chief Medical Officer | Sale | 10,720 | $97K | Form 4 |
| Dec 15, 2025 | Piscitelli Dominic CFO | Option | 29,333 | — | Form 4 |
| Dec 16, 2025 | Piscitelli Dominic CFO | Sale | 10,720 | $97K | Form 4 |
| Dec 15, 2025 | Chacko Jacob PRESIDENT AND CEO · Director | Option | 83,666 | — | Form 4 |
| Dec 16, 2025 | Chacko Jacob PRESIDENT AND CEO · Director | Sale | 33,374 | $302K | Form 4 |
| Dec 8, 2025 | Kunkel Lori Anne Director | Option | 10,000 | $79K | Form 4 |
| Dec 4, 2025 | Kunkel Lori Anne Director | Option | 5,534 | $21K | Form 4 |
| Oct 6, 2025 | Piscitelli Dominic CFO | Option | 11,000 | $48K | Form 4 |
| Oct 6, 2025 | Piscitelli Dominic CFO | Sale | 11,000 | $160K | Form 4 |
| Oct 6, 2025 | Chacko Jacob PRESIDENT AND CEO · Director | Sale | 37,461 | $462K | Form 4 |
| Oct 3, 2025 | Heyman Richard A. Director | Option | 1,447 | $5K | Form 4 |
| Oct 3, 2025 | Heyman Richard A. Director | Option | 31,353 | $50K | Form 4 |
| Sep 30, 2025 | Chacko Jacob PRESIDENT AND CEO · Director | Sale | 34,538 | $415K | Form 4 |
| Oct 1, 2025 | Chacko Jacob PRESIDENT AND CEO · Director | Sale | 53,001 | $639K | Form 4 |
| Sep 22, 2025 | Chacko Jacob PRESIDENT AND CEO · Director | Sale | 125,000 | $1.35M⚡ | Form 4 |
| Jul 1, 2025 | Piscitelli Dominic CFO | Sale | 20,000 | $201K | Form 4 |
| Jun 23, 2025 | Piscitelli Dominic CFO | Sale | 584 | $6K | Form 4 |
| Jun 23, 2025 | Piscitelli Dominic CFO | Sale | 450 | $5K | Form 4 |
| Jun 24, 2025 | Piscitelli Dominic CFO | Sale | 32,466 | $341K | Form 4 |
| Jun 23, 2025 | You Angie Director | Purchase | 1,403 | $13K | Form 4 |
Multani Pratik S
Chief Medical Officer
Date
Dec 16
Shares
10,720
Price
$9.06
Value
$97K
Chacko Jacob
PRESIDENT AND CEO · Director
Date
Dec 15
Shares
83,666
Price
—
Value
—
Chacko Jacob
PRESIDENT AND CEO · Director
Date
Dec 16
Shares
33,374
Price
$9.06
Value
$302K
Chacko Jacob
PRESIDENT AND CEO · Director
Date
Oct 6
Shares
37,461
Price
$12.32
Value
$462K
Chacko Jacob
PRESIDENT AND CEO · Director
Date
Sep 30
Shares
34,538
Price
$12.01
Value
$415K
Chacko Jacob
PRESIDENT AND CEO · Director
Date
Oct 1
Shares
53,001
Price
$12.05
Value
$639K
Chacko Jacob
PRESIDENT AND CEO · Director
Date
Sep 22
Shares
125,000
Price
$10.80
Value
$1.35M ⚡
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ORIC insider trading
ORIC insider trades
ORIC Pharmaceuticals, Inc. (ORIC) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Piscitelli Dominic (CFO), Chacko Jacob (PRESIDENT AND CEO · Director), Heyman Richard A. (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. ORIC insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For ORIC Pharmaceuticals, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ORIC insider trading · 5 questionsThe insiders of ORIC Pharmaceuticals, Inc. (ORIC) include executives and directors such as Piscitelli Dominic (CFO), Chacko Jacob (PRESIDENT AND CEO · Director), Heyman Richard A. (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026